Apolipoprotein-E genotyping of diabetic dementia patients: Is diabetes rare in Alzheimer's disease?

Journal of the American Geriatrics Society

Volumn 44, Issue 8, 1996, Pages 897-904

  Nielson, Kristy A ^a,c   Nolan, Jennifer H ^a   Berchtold, Nicole C ^a   Sandman, Curt A ^a,b   Mulnard, Ruth A ^a   Cotman, Carl W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSIS RELATED GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIINFARCT DEMENTIA; STROKE;

EID: 0029841499     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01857.x     Document Type: Article

References (44)

1. American Diabetes Association. Diabetes Facts. Alexandria, VA: American Diabetes Association, Inc., 1993.
2. Morley J, Perry HM 3rd. The management of diabetes mellitus in older individuals. Drugs 1991;41:548-565.
3. Gambert S. Defining the problem: Impact of diabetes mellitus on an aging society. In: Gambert S, Cooppan R, Gupta KL, eds. Diabetes Mellitus in the Elderly: A Practical Guide. New York: Raven Press, Ltd., 1990, pp 1-20.
4. Kahn R, Shechter Y. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Gilman A, Rail TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. New York: Pergamon, 1990, pp 1463-1495.
5. Skoog I. Risk factors for vascular dementia: A review. Dementia 1994;5:137-144.
6. Council on Scientific Affairs. Dementia. JAMA 1986;256:2234-2238.
7. Evans D, Funkenstein H, Albert M et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989;262:2251-2256.
8. Bucht G, Adolfsson R, Lithner R, Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 1983;213:387-392.
9. Landin K, Blennow K, Wallin A, Gottfries CG. Low blood pressure and blood glucose levels in Alzheimer's disease: Evidence for a hypometabolic disorder? J Intern Med 1993;233:357-363.
10. Mortel K, Wood S, Pavol MA et al. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology 1993;44:599-605.
11. Wolf-Klein G, Silverstone F, Brod M et al. Are Alzheimer patients healthier? J Am Geriatr Soc 1988;363:219-224.
12. Saunders AM, Schmader K, Breitner JC et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloidforming diseases. Lancet 1993;342:710-711.
13. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995;92:4725-4727.
14. Roses AD, Saunders AM, Corder EH et al. Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1995;92:4725-4727.
15. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
16. Chui H, Victoroff JI, Margolin D et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the Statef California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
17. Román G, Tatemichi T, Erkinjuntti T et al. Vascular dementia: Diagnostic criteria for research studies. Neurology 1993;43:250-260.
18. National Diabetes Data Group. Diabetes 1979;28:1039-1057.
19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
20. Administration on Aging (AoA). A profile of older Americans: 1994. Washington, D.C.: U.S. Dept. of Health and Human Services, 1994.
21. American Heart Association. Older Americans Fact Sheet. Alexandria, VA: American Heart Association, 1994.
22. National Health and Nutrition Examination Survey (NHANES III) 1988-1991. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-183.
23. Giles W, Kittner S, Hebel J et al. Determinants of black-white differences in the risk of cerebral infarction. The National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med 1995;155:1319-1324.
24. Thorvaldsen P, Asplund K, Kuulasmaa K et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 1995;26:361-367.
25. Utermann G, Langenbeck U, Beisiegel U, Weber W. Genetics of the apolipoprotein E system in man. Am J Hum Genet 1980;32:339-347.
26. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983;3:310-315.
27. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
28. Heinonen O, Lehtovirta M, Soininen H et al. Alzheimer pathology of patients carrying apolipoprotein E E4 allele. Neurobiol Aging 1995;16:505-513.
29. Corder EH, Saunders AM, Risch NJ et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.
30. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-580.
31. Salo MK, Rantanen R, Huupponen T et al. Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescents. Eur J Pediat 1993;152:564-568.
32. Shriver MD, Boerwinkle E, Hewett ED, Hanis CL. Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects. Diabetes 1991;40:334-337.
33. Krantz S, Stelter F, Lober M, Gromoll B. Complement component 3 (C3) genetics and diabetes mellitus. Biomed Biochim Acta 1990;49:1237-1241.
34. Katzman R, Terry R. The neurology of aging. Philadelphia: Davis Co., 1983, pp 1-14.
35. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
36. Frisoni GB, Calabresi L, Geroldi C et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
37. Amouyel P, Vidai O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 1994;344:1315-1318.
38. Ukkola O, Kervinen K, Salmela PI et al. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1993;101:9-15.
39. Gold AE, Deary IJ, Jones RW et al. Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: A complication of diabetes or a consequence of treatment? Diabet Med 1994;11:499-505.
40. Lowe LP, Tranel D, Wallace RB, Welty TK. Type II diabetes and cognitive function. A population-based study of Native Americans. Diabetes Care 1994;17:891-896.
41. Meneilly GS, Cheung E, Tessier D et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993;48:M117-121.
42. Richardson JT. Cognitive function in diabetes mellitus. Neurosci Biobehav Rev 1990;14:385-388.
43. Kurochkin I, Goto S. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994;345:33-37.
44. Snehalatha C, Timothy H, Mohan V et al. Immunoreactive insulin and insulin degrading enzyme in erythrocytes. A preliminary report. J Assoc Phys India 1990;38:558-561.